Stock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO

Stock Track

7 hours ago

SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.

The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.

SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1152577895"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1152577895\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1152577895?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-07 01:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152577895","market":"us","top_or_hot":-1,"title":"Stock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO","media":"Stock Track","content":"<p>SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.</p><p>The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.</p><p>SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-07 01:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.</p><p>The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.</p><p>SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGP","symbol_name":"SpyGlass Pharma Inc","start_time":0,"source_url":"","article_id":"1152577895","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152577895","pubTimestamp":1770398971,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.The biopharmaceutical company recently completed a $150...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SGP":"SpyGlass Pharma Inc"},"translate_title":"个股追踪|Spyglass Pharma 1.5亿美元IPO后纳斯达克首秀盘中大涨50%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGP":1},"content_text":"SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}